Management of MSI-H/dMMR Upper and Lower Gastrointestinal Cancers
Clinicians need to be informed about the importance of MSI-H/dMMR testing in patients with GI tumors and updated on the most recent clinical evidence to ensure that they select the most appropriate treatment options for their patients.
  • Anal Carcinoma
  • Colorectal Cancer
  • Gastric/Esophageal Cancer
  • Rectal Cancer
  • Recorded Webcast
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation